Niphelate Q

Nifelat-Q is a brand name for an antihypertensive drug that acts on the basis of a group of calcium channel blockers, the drug nifedipic acid. The drug is an important component among various classes of drugs used in the treatment of hypertension and angina pectoris. The pharmacological effectiveness of Nifelat-Q is based on its ability to increase the ability of blood vessels to dilate, which leads to a decrease in blood pressure. This results in a clinically significant reduction in blood viscosity and improved circulation. Production is carried out by Remsica Ltd (Cyprus).